Smart Hip Monitors Real-time Performance Of Bone Implants
To monitor the real-time performance of bone implants is the challenge of "Smart Hip", an innovative medical device that aims to reduce the number of surgical interventions in the hip area and regenerate bone tissue by using non-evasive methods. The concept's validation unique in the world and developed by a PHD from the Faculty of Engineering of the University of Porto, has already been successfully tested on animals. It is estimated that there are about a million surgeries in Europe and USA in the hip joint, and that 5% to 10% of these surgeries eventually generates further health problems, which usually demands a new surgery for review. But the solution to this problem may now be closer.
When To Perform Bone Scan In Patients With Newly Diagnosed Prostate Cancer: Validation Of Available Guidelines, Risk Stratification Tool Proposal
UroToday.com - Prostate cancer (CaP) patients often undergo a routine bone scan as part of their metastatic evaluation at the time of diagnosis. Most consensus recommendations suggest obtaining bone scans only in patients with risk characteristics suggesting reasonable utility for this test. However, according to a paper by Dr. Alberto Briganti and colleagues in an online publication in European Urology these guidelines are neither based upon contemporary patient cohorts nor have they been externally validated. These investigators sought to externally validate and test the performance characteristics of the current EAU, AUA, AJCC, and NCCN recommendations on the need for baseline staging bone scans in a large cohort of men with newly diagnosed CaP.
Multi-Center Data In A Large Series Of Patients Show Vertebroplasty Provides Dramatic And Lasting Pain Relief For Vertebral Compression Fractures
The results of a study of more than 4500 patients from six Italian EVEREST (European Vertebroplasty Research Team) Centers (Dr. G.C. Anselmetti-Candiolo Torino, Dr. G. Bonaldi-Bergamo, Dr. P. Carpeggiani-Pisa, Dr. S. Masala-Roma, Dr. M. Muto-Napoli, ) confirms the effectiveness of vertebroplasty in treating vertebral compression fractures (VCFs), finding that the procedure provides significant and sustained pain relief. Patients had immediate relief of back pain and were able to discontinue taking analgesics immediately following the procedure. Vertebroplasty is an outpatient procedure performed under local anesthesia and involves injecting bone cement into the collapsed vertebral body.
A Winning Strategy: Don't Play Through Pain
Sometimes athletes can be their own worst enemy especially when they continue to play following an injury to a foot or ankle. Surgeons presenting at the Annual Scientific Conference of the American College of Foot and Ankle Surgeons (ACFAS) are discussing athletic injuries and the importance of proper diagnosis, prompt treatment, and full healing and rehabilitation. Athletes often misunderstand how serious an injury can be and try to rush back into competition without appropriate treatment and rehabilitation. Some of the most difficult cases seen by foot and ankle surgeons are those in which athletes have continued to play after an injury. ACFAS conference speaker and Orlando, Florida, foot and ankle surgeon, Robert Duggan, DPM, FACFAS, says, "Athletes often make the mistake of ignoring what seems like a minor foot or ankle injury because they are able to walk.
Small Bone Innovations, Inc. Receives US FDA 510 k Clearance For Mini-Rail Fixation System And Large Cannulated Screw System
Small Bone Innovations, Inc. (SBi), a leading, privately-held orthopedics company focused exclusively on technologies and treatments for the small bones & joints, announced that it has received 510(k) pre-market clearance notifications from the U.S. Food and Drug Administration (FDA) for Mini-Rail Fixation System ('Mini-Rail System') and large Cannulated Screw System for use in lower limb reconstruction and repair procedures. The Mini-Rail and Cannulated Screw systems further expand SBi's lower limb continuum of care product line. SBi expects its Mini-Rail System to be used in common procedures such as first MTP (metatarsophalangeal) joint arthrodesis and distraction, subtalar fusion, and Jones fracture management.
New Program Helps Prevent Fragility Fractures
As many as half of all women and a quarter of men over the age of 50 can expect to sustain a fractured bone related to osteoporosis or low bone density. To enhance prevention and treatment of these fragility fractures, NewYork-Presbyterian Hospital/Columbia University Medical Center has implemented an innovative program called Own the Bone™ developed by the American Orthopaedic Association. "Research has shown that patients who have had a fragility fracture are four times more likely to experience another fracture than those who have never had a fracture. The Own the Bone program will help us ensure that our patients with fragility fractures are screened and appropriately treated for osteoporosis, " says Dr.
FDA Classifies Prolia TM Denosumab Complete Response Submission And Targets Action Date
Amgen Inc. (Nasdaq: AMGN) announced that the U.S. Food and Drug Administration (FDA) has evaluated the content of the Company's Complete Response submission for Prolia(TM) (denosumab) in the treatment of postmenopausal osteoporosis and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act (PDUFA) action date of July 25, 2010. In October 2009, the FDA's Division of Reproductive and Urologic Products issued a Complete Response Letter for the Biologic License Application (BLA) for Prolia in the treatment and prevention of postmenopausal osteoporosis. The letter requested several items, including further information on the design of Amgen's previously submitted post-marketing surveillance program.
Hospital For Special Surgery Launches Quality Research Center
Patients with orthopedic and autoimmune conditions expect Hospital for Special Surgery (HSS)--because of its leadership role--to deliver the highest quality care. To further accomplish this mission, HSS is announcing the creation of a Quality Research Center with an innovative structure for applying research methodologies to health-care quality issues. Physicians, nurses and biostatisticians throughout the institution will now, through this new initiative, work together on conducting research in areas that impact on quality of patient care and patient safety. The research generated from the Center will enable HSS to improve best practices to benefit its patients and also allow HSS to provide evidence-based data that can be published and disseminated to other institutions.
Osteoporosis Research: Record Number Of Abstracts Received For The IOF WCO-ECCEO10
More than 850 abstracts have been received - guaranteeing broad global attendance at the year's most noteworthy platform for osteoporosis research. Don't miss the most important osteoporosis meeting of 2010, to be held in the center of Florence, Italy from May 5 to 8, 2010. Take advantage of lower rates: early bird registration rates still available before March 10, 2010. Spring is a great time to be in Florence and hotel accommodation in the center of the city fills up quickly. Make sure you reserve your accommodation as soon as possible. The IOF WCO-ECCEO10 is expected to attract some 5000 researchers and clinicians from all continents. Featuring: Stimulating plenary lectures on varied 'hot' topics delivered by the field's top experts Clinically-focused Meet-the-Expert Sessions, restricted in size for maximum interaction among participants Special sessions give in-depth coverage of specific topics: VPHOP Symposium: Assessing Fracture Risk: The Future for Designing New Therapies IOF Minisymposium - Growth and Development of the Skeleton ESCEO Session: Dermatological Side Effects of Antiosteoporosis Medications ESCEO Session: Management of Osteoporosis in the Very Elderly ESCEO Session: Subtrochanteric Fractures After Long-Term Use of Bisphosphonates ESCEO-ASBMR Joint Symposium - Rare Bone Disorders: Impact in Drug Development ESCEO-GREES Roundtable - Relationship between Pharmaceutical Industry and Academic Scientists: Suggestions for a New Code of Conduct Symposium on behalf of FIRMO, SIMG, SIOMMMS and SIOT under the auspices of ESCEO Fragility Fractures: The Italian Effort for the Recognition of the Problem See you in Florence!
AdvaCAL Calcium Effective Against Bone Loss In Postmenopausal Women
With Osteoporosis an increasing concern among women of all ages, a recent report in the medical journal Osteoporosis International found that women taking the AAACa (AdvaCAL® ) calcium supplements had the highest bone density increase among 32 different calcium studies conducted between 1977 and 2008. The 32 studies involved 3, 169 postmenopausal women, 79 skeletal measures and 7 different types of calcium, including dairy. The report entitled "The Effect of Calcium Supplementation on Bone Loss in 32 Controlled Trials in Postmenopausal Women" was authored by calcium researcher Christopher Nordin, M.D. of Australia. Nordin concluded that calcium intake prevented bone loss in postmenopausal women for at least four years.